Vertex Pharmaceuticals
Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
VRTX Key Statistics
Stock Snapshot
The current Vertex Pharmaceuticals(VRTX) stock price is $467.00, with a market capitalization of 119.37B. The stock trades at a price-to-earnings (P/E) ratio of 28.28.
During the trading session on 2026-08-03, Vertex Pharmaceuticals(VRTX) shares reached a daily high of $484.30 and a low of $466.00. At a current price of $467.00, the stock is +0.2% higher than the low and still -3.6% under the high.
Trading activity shows a volume of 1.49M, compared to an average daily volume of 1.3M.
The stock's 52-week range extends from a low of $362.50 to a high of $533.67.
The stock's 52-week range extends from a low of $362.50 to a high of $533.67.
VRTX News
Reports Q2 revenue $3.33B, consensus $3.22B. “Vertex delivered excellent second quarter results, expanding our leadership in cystic fibrosis; delivering strong...
Vertex raised its full year 2026 total revenue guidance to $13.1 billion to $13.2 billion from $12.95 billion to $13.1 billion previously. Embedded in this guid...
...
Analyst ratings
78%
of 32 ratingsMore VRTX News
In July 2026, AbCellera Biologics announced a collaboration with Vertex Pharmaceuticals to research, develop, manufacture, and commercialize multispecific T-cel...
Advertisement Vertex Pharmaceuticals stock reaction to new AbCellera collaboration Vertex Pharmaceuticals (VRTX) drew fresh attention after AbCellera Biologic...
Vertex Pharmaceuticals stock has delivered a strong 5 year return of 145.1%. However, the current checks send a mixed message, with a Discounted Cash Flow (DCF)...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.